AGT and achalasia-alacrima syndrome: Chronic infusion of angiotensin-II (AngII), a major bioactive peptide of the renin–angiotensin system (RAS), into hypercholesterolemic mice for 28 days via osmotic minipump leads to the development of AAAs only in male mice in a dose-dependent manner [4,5].